G. A. Veldink, J. F. Vliegenthart, and J. Boldingh, Plant lipoxygenases, Progress in the Chemistry of Fats and Other Lipids, vol.15, pp.90014-90017, 1977.

R. W. Bryant and J. M. Bailey, Role of selenium-dependent glutathione peroxidase in platelet lipoxygenase metabolism, Prog. Lipid Res, vol.20, pp.189-194, 1981.

P. Chen, E. Véricel, M. Lagarde, and M. Guichardant, Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation, FASEB J, vol.25, pp.382-388, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00517396

C. N. Serhan, R. Yang, K. Martinod, K. Kasuga, P. S. Pillai et al., Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions, J. Exp. Med, vol.206, pp.15-23, 2009.

C. N. Serhan, J. Dalli, R. A. Colas, J. W. Winkler, and N. Chiang, Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome, Biochim. Biophys. Acta, vol.1851, pp.397-413, 2015.

M. Lagarde, C. Calzada, C. Jouvène, N. Bernoud-hubac, M. Létisse et al., Functional fluxolipidomics of polyunsaturated fatty acids and oxygenated metabolites in the blood vessel compartment, Prog. Lipid Res, vol.60, pp.41-49, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01228992

P. Borgeat, B. Fruteau-de-laclos, S. Picard, J. Drapeau, P. Vallerand et al., Studies on the mechanism of formation of the 5S, vol.23, pp.713-724, 1982.

C. A. Dahinden, R. M. Clancy, and T. E. Hugli, Stereospecificity of leukotriene B4 and structure-function relationships for chemotaxis of human neutrophils, J. Immunol, vol.133, pp.1477-1482, 1984.

M. Croset and M. Lagarde, Stereospecific inhibition of PGH2-induced platelet aggregation by lipoxygenase products of icosaenoic acids, Biochem. Biophys. Res. Commun, vol.112, pp.878-883, 1983.

R. L. Maas, A. R. Brash, and J. A. Oates, A second pathway of leukotriene biosynthesis in porcine leukocytes, Proc. Natl. Acad. Sci. U.S.A, vol.78, pp.5523-5527, 1981.

R. Sehmi, O. Cromwell, G. W. Taylor, A. B. Kay, ;. et al., Identification of guinea pig eosinophil chemotactic factor of anaphylaxis as leukotriene B4 and 8(S),15(S)-dihydroxy5, J. Immunol, vol.9, issue.13, pp.2276-2283, 1991.

M. I. Aveldaño and H. Sprecher, Synthesis of hydroxy fatty acids from 4, vol.7, pp.9339-9343, 1983.

P. Chen, B. Fenet, S. Michaud, N. Tomczyk, E. Véricel et al., Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation, FEBS Lett, vol.583, pp.3478-3484, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00429322

C. N. Serhan and N. Chiang, Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus, Br. J. Pharmacol, vol.153, issue.1, pp.200-215, 2008.

M. Dona, G. Fredman, J. M. Schwab, N. Chiang, M. Arita et al., Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets, Blood, vol.112, pp.848-855, 2008.

M. Lagarde, E. Véricel, M. Liu, P. Chen, and M. Guichardant, Structure-function relationships of non-cyclic dioxygenase products from polyunsaturated fatty acids: poxytrins as a class of bioactive derivatives, Biochimie. 107 Pt A, pp.91-94, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-01072459

M. Liu, T. Boussetta, K. Makni-maalej, M. Fay, F. Driss et al., Protectin DX, a double lipoxygenase product of DHA, inhibits both ROS production in human neutrophils and cyclooxygenase activities, Lipids, vol.49, pp.49-57, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-00909219

P. J. White, P. St-pierre, A. Charbonneau, P. L. Mitchell, E. St-amand et al., Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis, Nat. Med, vol.20, pp.664-669, 2014.

K. Stein, M. Stoffels, M. Lysson, B. Schneiker, O. Dewald et al., A role for 12/15-lipoxygenase-derived proresolving mediators in postoperative ileus: protectin DX-regulated neutrophil extravasation, J. Leukoc. Biol, vol.99, pp.231-239, 2016.

T. W. Jung, Y. H. Chung, H. Kim, A. M. El-aty, and J. H. Jeong, Protectin DX attenuates LPS-induced inflammation and insulin resistance in adipocytes via AMPKmediated suppression of the NF?B pathway, Am. J. Physiol. Endocrinol. Metab, 2018.

X. Zhuo, Y. Hao, F. Cao, S. Yan, H. Li et al., Protectin DX increases alveolar fluid clearance in rats with lipopolysaccharide-induced acute lung injury, Exp. Mol. Med, vol.50, p.49, 2018.

M. Morita, K. Kuba, A. Ichikawa, M. Nakayama, J. Katahira et al., The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza, Cell, vol.153, pp.112-125, 2013.

L. Balas, M. Guichardant, T. Durand, and M. Lagarde, Confusion between protectin D1 (PD1) and its isomer protectin DX (PDX). An overview on the dihydroxy-docosatrienes described to date, Biochimie, vol.99, pp.1-7, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00952184

Y. Imai, Role of omega-3 PUFA-derived mediators, the protectins, in influenza virus infection, Biochim. Biophys. Acta, vol.1851, pp.496-502, 2015.

P. L. Mitchell, R. Nachbar, D. Lachance, P. St-pierre, J. Trottier et al., Treatment with a novel agent combining docosahexaenoate and metformin increases protectin DX and IL-6 production in skeletal muscle and reduces insulin resistance in obese diabetic db/db mice, Diabetes Obes Metab, vol.19, pp.313-319, 2017.

R. Kosaraju, W. Guesdon, M. J. Crouch, H. L. Teague, E. M. Sullivan et al., B Cell Activity Is Impaired in Human and Mouse Obesity and Is Responsive to an Essential Fatty Acid upon Murine Influenza Infection, J. Immunol, vol.198, pp.4738-4752, 2017.

C. Jouvène, B. Fourmaux, A. Géloën, L. Balas, T. Durand et al., Ultra-Performance Liquid Chromatography-Mass Spectrometry Analysis of Free and Esterified Oxygenated Derivatives from Docosahexaenoic Acid in Rat Brain, Lipids, vol.53, pp.103-116, 2018.

T. Shimizu, O. Rådmark, and B. Samuelsson, Enzyme with dual lipoxygenase activities catalyzes leukotriene A4 synthesis from arachidonic acid, Proc. Natl. Acad. Sci. U.S.A, vol.81, pp.689-693, 1984.

B. Samuelsson and C. D. Funk, Enzymes involved in the biosynthesis of leukotriene B4, J. Biol. Chem, vol.264, pp.19469-19472, 1989.

M. Liu, P. Chen, E. Véricel, M. Lelli, L. Béguin et al., Characterization and biological effects of di-hydroxylated compounds deriving from the lipoxygenation of ALA, J. Lipid Res, vol.54, pp.2083-2094, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00832286

M. Lagarde, M. M. Boutillon, M. Guichardant, J. P. Lellouche, J. P. Beaucourt et al., Further studies on the anti-thromboxane A2 activity of monohydroxylated fatty acids, Biochem. Pharmacol, vol.38, pp.1863-1864, 1989.

C. N. Serhan, G. Fredman, R. Yang, S. Karamnov, L. S. Belayev et al., Novel proresolving aspirin-triggered DHA pathway, Chem. Biol, vol.18, pp.976-987, 2011.

M. Shinohara, V. Mirakaj, and C. N. Serhan, Functional Metabolomics Reveals Novel Active Products in the DHA Metabolome, Front Immunol, vol.3, p.81, 2012.